凱(kai)瑞(rui)斯(si)德成(cheng)立(li)于(yu)(yu)2000年,擁(yong)有國際先進的不(bu)對稱氫化技(ji)術,致力(li)于(yu)(yu)為(wei)全球(qiu)創(chuang)新藥公(gong)司(si)(si)提(ti)(ti)供中(zhong)間(jian)體(ti)定制生(sheng)產服務,包括研(yan)發(fa)、中(zhong)試(shi)到商業(ye)化生(sheng)產。公(gong)司(si)(si)總部及研(yan)發(fa)中(zhong)心(xin)(xin)位于(yu)(yu)蘇州(zhou)工(gong)(gong)業(ye)園(yuan)(yuan)區(qu),2009年凱(kai)瑞(rui)斯(si)德收購江西隆萊生(sheng)物(wu)制藥有限公(gong)司(si)(si)作為(wei)公(gong)司(si)(si)的生(sheng)產基地(di)。生(sheng)產基地(di)位于(yu)(yu)江西省(sheng)進賢(xian)縣工(gong)(gong)業(ye)園(yuan)(yuan)區(qu),另外,公(gong)司(si)(si)在美國、歐(ou)洲(zhou)和印度都(dou)設有辦事(shi)處。公(gong)司(si)(si)以技(ji)術為(wei)依托(tuo)、以人才為(wei)根(gen)本(ben),已獲得(de)國家高新技(ji)術企(qi)業(ye)、蘇州(zhou)市不(bu)對稱氫化工(gong)(gong)程(cheng)技(ji)術研(yan)究中(zhong)心(xin)(xin)、蘇州(zhou)工(gong)(gong)業(ye)園(yuan)(yuan)區(qu)科技(ji)“雙(shuang)百工(gong)(gong)程(cheng)”企(qi)業(ye)和江蘇省(sheng)博士后創(chuang)新實踐基地(di)等認證。并擁(yong)有13項(xiang)手(shou)性(xing)催化劑和配體(ti)的國際專利,8項(xiang)仿制藥合成(cheng)新工(gong)(gong)藝專利。凱(kai)瑞(rui)斯(si)德的宗旨是利用(yong)技(ji)術優勢,為(wei)全球(qiu)生(sheng)物(wu)醫藥公(gong)司(si)(si)提(ti)(ti)供可靠(kao)的醫藥中(zhong)間(jian)體(ti)和原料藥,同時(shi)提(ti)(ti)供新藥研(yan)發(fa)服務。
凱瑞(rui)斯德(de)研發(fa)(fa)中(zhong)心位(wei)于蘇州工業園(yuan)區(qu)生物納米園(yuan),公(gong)司擁有高(gao)(gao)層(ceng)次的研發(fa)(fa)團隊,其中(zhong)博士7人(ren),海外專家5人(ren),碩士13人(ren)。公(gong)司開發(fa)(fa)的手(shou)性催化(hua)劑具有高(gao)(gao)效、高(gao)(gao)選擇性、低成(cheng)(cheng)本和多(duo)種底物普遍適(shi)用性等(deng)特點(dian)。這些催化(hua)劑已經成(cheng)(cheng)功商業化(hua),并(bing)應用于多(duo)種手(shou)性高(gao)(gao)級醫藥(yao)中(zhong)間體(ti)的合成(cheng)(cheng)。